跳至主要内容
临床试验/NCT03400384
NCT03400384已完成不适用

Using Policy to Reduce Opioids by Educating and Empowering Patients With Chronic Non-cancer Pain: The TAPERING Randomised Trial.

Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal2 个研究点 分布在 1 个国家目标入组 4,255 人开始时间: 2018年7月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
4,255
试验地点
2
主要终点
Complete cessation of opioids

研究概览

简要总结

To assess the effectiveness of a government-led population-based opioid intervention on discontinuation of opioid medication in community-dwelling adults with chronic non-cancer pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults registered to receive pharmaceutical benefits in Manitoba, who are aged 18 years and over and who have received ≥90 days supply of opioids in the 6 months prior to the trial will be included. This will ensure chronic use and episodic use of opioids will be included.

排除标准

  • People receiving palliative care, people with cancer, and people who receive opioids in hospital. People with dementia (identified by having received a prescription for memantine or a cholinersterase inhibitor in the previous 12 months) will be excluded.

结局指标

主要结局

Complete cessation of opioids

时间窗: 6 months

Provincial prescription insurance claims will be used to measure whether or not opioids are dispensed to community-dwelling adults randomized to either the intervention or control groups between baseline and 6-month follow up. Prescription data contain information on all dispensed prescriptions including drug name, dispensing date, dosage, drug form, the quantity of the drug dispensed, and the license number of the physician who wrote the prescription. Discontinuation of an opioid will be defined as the lack of a prescription claim for at least 60 days.

次要结局

  • Dose reduction or therapeutic switch to an alternate analgesic(6 months)
  • The proportion of people achieving opioid doses below 90mg oral morphine equivalents.(6 months)

研究者

发起方
Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
申办方类型
Other
责任方
Principal Investigator
主要研究者

Cara Tannenbaum

Professor in the faculties of Medicine and Pharmacy, University of Montreal

Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal

研究点 (2)

Loading locations...

相似试验